Financhill
Back

NovoCure 10K Form

Sell
50

NVCR
NovoCure

Last Price:
76.84
Seasonality Move:
0.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive NVCR News And Ratings

See the #1 stock for the next 7 days that we like better than NVCR

NVCR Financial Statistics

Sales & Book Value

Annual Sales: $535.03M
Cash Flow: $11.63M
Price / Cash Flow: 332.16
Annual Sales: $4.22
Price / Book: 18.26

Profitability

EPS (TTM): -0.65000
Net Income (TTM): $-68.24M
Gross Margin: $420.15M
Return on Equity: -16.26%
Return on Assets: -6.02%

NovoCure Earnings Forecast

Key NovoCure Financial Ratios

  • The Gross Profit Margin over the past 9 years for NVCR is 78.53%.
  • The Selling, General & Administrative Expenses for NVCR have been equal to 49.19% of Gross Profit Margin.
  • The Research & Development expenses have been 37.62% of Revenue.
  • The Interest Expense is -5.90% of Operating Income.
  • The Net Earning history of NVCR is -10.91% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

NovoCure Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical Instruments & Supplies
Sector: Healthcare
Current Symbol: NVCR
CUSIP: G6674U
Website: novocure.com

Debt

Debt-to-Equity Ratio: 1.28
Current Ratio: 8.08
Quick Ratio: 7.86

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NVCR Technical Analysis vs Fundamental Analysis

Sell
50
NovoCure (NVCR) is a Sell

Is NovoCure a Buy or a Sell?

  • NovoCure stock is rated a Sell
    The current NovoCure [NVCR] share price is $76.84. The Score for NVCR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.